Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA recruitment notice 'No longer looking for participants' was added. New user-help sections were introduced, the Intervention/Treatment label was standardized, and the revision version updated to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedThe revision indicator at the bottom of the page was updated from v3.5.4 to v3.5.5, signaling a deployment update. This reflects an underlying site update rather than a change to the study content or results.SummaryDifference0.1%

- Check38 days agoChange DetectedPublications section updated: a new bibliographic citation for Shen L et al. on tislelizumab in Chinese patients was added, including author names and source details. The Erratum entry previously listed was removed and the revision version updated to v3.5.4.SummaryDifference0.1%

- Check59 days agoChange DetectedThe footer revision/version label on the ClinicalTrials.gov study page was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a new publication entry for Shen L et al. (J Immunother Cancer, 2020) with an Erratum and updated the publication revision from v3.5.0 to v3.5.2; the previous citation entry was removed.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision label updated to v3.5.0 and v3.4.3 was removed. This is a metadata/version update and does not modify study data or content.SummaryDifference0.1%

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.